L2 MEDICAL DEVELOPMENT CO
L2 MEDICAL DEVELOPMENT CO (SCQO) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 8 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Sep 4, 2013 involved a transaction of 450,436 shares valued at $0.
SCQO Insider Activity Summary
Who Is Buying SCQO Stock?
No significant insider buying has been recorded for SCQO in the recent period.
Who Is Selling SCQO Stock?
No significant insider selling has been recorded for SCQO in the recent period.
Is L2 MEDICAL DEVELOPMENT CO Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SCQO is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
SCQO Frequently Asked Questions
Understanding SCQO Insider Activity
Insider trading at L2 MEDICAL DEVELOPMENT CO (SCQO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading SCQO stock, having executed 8 transactions in the past 90 days. The most active insider is Louis S. Camilli (Executive), who has made 1 transactions totaling $0.
Related Tools
Track L2 MEDICAL DEVELOPMENT CO Insider Activity
Get notified when executives and directors at SCQO file new Form 4 transactions